ORFLO introduces new Moxi Z mini cell counter

NewsGuard 100/100 Score

ORFLO Technologies announced the international launch of Moxi™ Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.

"The Moxi Z mini cell counter sets a new bar for the cell counting community," said Manju Sethi, Vice President of Business Development, "The instrument eliminates virtually all of the drawbacks of current cell counting methods."

Today, cell counting is often performed by using hemocytometers that involve laborious manual counting or by using large, imprecise image-based counting systems.  When more accurate data is needed, scientists turn to flow cytometers that can be very costly.

Moxi Z combines two powerful methods, the Coulter Principle which is the gold standard for cell counting and a patented thin-film sensor technology developed by ORFLO.  This unique instrument has the performance of high-end instruments yet is miniaturized, affordable and simple to operate without the need for costly reagents or maintenance contracts.  

In just 8 seconds per measurement, the instrument provides accurate cell size and count determinations and an indicator of dead versus live cells with its Moxi Viability Index - an important criterion for scientists who are analyzing cell cultures.  The Moxi Z is the first portable instrument to provide cell viability without the use of reagents or dyes.  Moxi Z's disposable cassettes offer superior ease of use and cost effectiveness with two tests per cassette.

"Cell science is evolving rapidly today, and Moxi z plays a revolutionary role in optimizing the scientist's toolkit to quickly and affordably answer many of the quantitative and qualitative questions that scientists ask themselves about their cell cultures," summarizes Ted Ayliffe, ORFLO founder and CEO.

Source:

ORFLO Technologies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluent BioSciences awarded NIH SBIR grant to commercialize low-cost million-cell transcriptome profiling kits